# Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk

> **NCT00814723** · PHASE4 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 90 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** fluvastatin
- **DRUG:** Fluvastatin plus ezetimibe

## Key facts

- **NCT ID:** NCT00814723
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2008-12-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814723, "Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00814723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*